31DEC

Welcome To Mediterr J Med Med Sci

Manuscripts are accepted for consideration with understanding that they are represent original material and they are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Cheif (Fmosherif@yahoo.com).
Mediterranean Journal of Medicine and Medical Sciences
https://mmj.org.ly/article/doi/10.5281/zenodo.17014538

Mediterranean Journal of Medicine and Medical Sciences

REVIEW

A brief overview of medicinal plants to treat Inflammatory Bowel Diseases

Iftear Kazim Rafi, Mahmudul Hasan Bhuiyan

http://dx.doi.org/10.5281/zenodo.17014538 Mediterr J Med Med Sci, vol.1, n2, p.23-31, 2025
PDF
Downloads: 1
Views: 313

Abstract

The term inflammatory bowel disease refers to a group of idiopathic conditions marked by persistent inflammation of the gastrointestinal tract. Individuals who have been diagnosed with inflammatory bowel disease frequently require long-term medication. Due to its ease of use and widespread application, oral administration has become one of the most preferred modes of treatment for inflammatory bowel disease. The effectiveness of oral herbal medical preparations and their extracts as a treatment for inflammatory bowel disease has been examined in recent years. As a result, strong evidence has emerged for their efficacy in treating inflammatory bowel disease. This review focuses on medicinal plants' applications, pharmacological characteristics, and efficacy. The outcomes offer a viable avenue for more study and the creation of plant-based treatments to enhance the treatment of inflammatory bowel disease and improves patient outcomes.

Keywords

IBD, Medicinal plant, PDVLN, ulcerative colitis

References

  1. Agrawal M, Spencer EA, Colombel JF, Ungaro RC. Approach to the management of recently diagnosed inflammatory bowel disease patients: A user's guide for adult and pediatric gastroenterologists. Gastroenterology. 2021; 161(1): 47-65. doi: 10.1053/j.gastro.2021.04.063
  2. Levi-Galibov O, Lavon H, Wassermann-Dozorets R, Pevsner-Fischer M, Mayer S, Wershof E, et al. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer. Nature Communications. 2020; 11(1): 6245. doi: 10.1038/s41467-020-20054-x
  3. Sun Y, Li L, Xia Y, Li W, Wang K, et al. The gut microbiota heterogeneity and assembly changes associated with the IBD. Scientific Reports. 2019; 9: 440. doi: 10.1038/s41598-018-37143-z
  4. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology. 2016; 14(8): e1002533. doi: 10.1371/journal.pbio.1002533
  5. Aktaruzzaman Md. Exploring helicobacter pylori infection, diagnosis, and prospect. Mediterranean Journal of Medicine and Medical Sciences. 2025; 1(1): 14-21. doi: 10.5281/zenodo.15713051
  6. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nature Reviews Gastroenterology and Hepatology. 2015; 12(4): 205-217. doi: 10.1038/nrgastro.2015.34
  7. de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: Mechanistic insights. Gut. 2022; 71(5): 1020-1032. doi: 10.1136/gutjnl-2021-326789
  8. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012; 338(6103): 120-123. doi: 10.1126/science.1224820
  9. Wong SH, Yu J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nature Reviews Gastroenterology and Hepatology. 2019; 16(11): 690-704. doi: 10.1038/s41575-019-0209-8
  10. Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, et al. Extracellular vesicles: The next generation theragnostic nanomedicine for inflammatory bowel disease. International Journal of Nanomedicine. 2022; 17: 3893-3911. doi: 10.2147/IJN.S370784
  11. Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. International Journal of Molecular Sciences. 2021; 22(21): 11365. doi: 10.3390/ijms222111365
  12. Wang H, Ye C, Wu Y, Yang P, Chen C, Liu Z, Wang X. Exosomes in inflammatory bowel disease: What have we learned so far? Current Drug Targets. 2020; 21(14): 1448-1455. doi: 10.2174/1389450121666200428 102330
  13. Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101: 321-340. doi: 10.1016/ j.biomaterials.2016.06.018
  14. Wan F, Wang M, Zhong R, Chen L, Han H, Liu L, et al. Supplementation with Chinese medicinal plant extracts from Lonicera hypoglauca and Scutellaria baicalensis Mitigates colonic inflammation by regulating oxidative stress and gut microbiota in a colitis mouse model. Frontiers in Cellular and Infection Microbiology. 2022; 11: 798052. doi: 10.3389/fcimb.2021.798052
  15. Ahmed R, Khandaker MS. Natural products as of nutraceuticals treatment for neurological disorders: An overview. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 62-69. doi: 10.5281/ zenodo.15226021
  16. Akhlaq M, Alum MK, Alam MM. Anti-inflammatory potential of medicinal plants. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 13-21. doi: 10.5281/zenodo.6399381
  17. Sami A, Usama M, Saeed MM, Akram M. Medicinal plants with non-steroidal anti-inflammatory -like activity. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2021; 1(3): 25-32. doi: 10.5281/zenodo. 5534605
  18. Bazine HA, Shlaka MA, Sherif FM. A neuropharmacological profile of lycium schweinfurthii (solanaceae) methanolic extract in mice. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(1): 43-50. doi: 10.5281/zenodo.7771364
  19. Hoque M, Hasan MN, Saikh S. Using common medicinal plants to treat high blood pressure: An updated overview and emphasis on antihypertensive phytochemicals. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(3): 1-10. doi: 10.5281/zenodo.15788473
  20. Obel MA, Asfoor TAT. The potential of endemic medicinal plants in the central regions of Abyan Governorate, Yemen for sustainable pharmaceutical applications. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(3): 46-51. doi: 10.5281/zenodo.16537815
  21. Wu X, Yang Y, Dou Y, Ye J, Bian D, Wei Z, Dai Y. Arctigenin but not arctiin acts as the major effective constituent of Arctium lappa L. fruit for attenuating colonic inflammatory response induced by dextran sulfate sodium in mice. International Immunopharmacology. 2014; 23(2): 505-515. doi: 10.1016/j.intimp.2014.09.026
  22. HyamSR, Lee IA, GuW, KimKA, Jeong JJ, Jang SE, HanMJ, KimDH. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages. European Journal of Pharmacology 2013; 708(1-3): 21-29. doi: 10.1016/j.ejphar.2013.01.014
  23. Wu X, Dou Y, Yang Y, Bian D, Luo J, Tong B, et al. Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway. Biochemical Pharmacology. 2015; 96: 323-336. doi: 10.1016/j.bcp.2015.06.008
  24. De Almeida ABA, Sánchez-Hidalgo M, Martín AR, Luiz-Ferreira A, Trigo JR, Vilegas W, et al. Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model. Journal of Ethnopharmacology. 2013; 146: 300-310. doi: 10.1016/j.jep.2012.12.048
  25. Huang TC, Tsai SS, Liu LF, Liu YL, Liu HJ, Chuang KP. Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model. World Journal of Gastroenterology. 2010; 16: 4193-4199. doi: 10.3748/wjg.v16. i33.4193
  26. dos Santos DA, Fukui MJ, Dhammika NP, Khan SI, Sousa JP, Bastos JK, et al. Anti-inflammatory and antinociceptive effects of Baccharis dracunculifolia DC (Asteraceae) in different experimental models. Journal of Ethnopharmacology. 2010; 127(2): 543-550. doi: 10.1016/j.jep.2009.09.061
  27. Guimarães NS, Mello JC, Paiva JS, Bueno PC, Berretta AA, Torquato RJ, Nantes IL, Rodrigues T. Baccharis dracunculifolia, the main source of green propolis, exhibits potent antioxidant activity and prevents oxidative mitochondrial damage. Food Chemistry and Toxicology. 2012; 50(3-4): 1091-1097. doi: 10.1016/j.fct.2011.11. 014
  28. Cestari SH, Bastos JK, Di Stasi LC. Intestinal anti-inflammatory activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic acid model of rat colitis. Evidence-Based Complementary Alternative Medicine. 2011; 2011: 524349. doi: 10.1093/ecam/nep081
  29. Paulino N, Abreu SR, Uto Y, Koyama D, Nagasawa H, Hori H, et al. Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. European Journal of Pharmacology. 2008; 587(1-3): 296-301. doi: 10.1016/j.ejphar.2008.02.067
  30. Hata T, Tazawa S, Ohta S, Rhyu MR, Misaka T, Ichihara K. Artepillin C, a major ingredient of Brazilian propolis, induces a pungent taste by activating TRPA1 channels. PLoS One. 2012; 7(11): e48072. doi: 10.1371/ journal.pone.0048072
  31. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Alimentary Pharmacology and Therapeutics. 2004; 19(5): 521-527. doi: 10.1111/j.1365-2036.2004. 01874.x
  32. Bahrami G, Malekshahi H, Miraghaee S, Madani H, Babaei A, Mohammadi B, Hatami R. Protective and therapeutic effects of Aloe Vera gel on ulcerative colitis induced by acetic acid in rats. Clinical Nutrition Research. 2020; 9(3): 223-234. doi: 10.7762/cnr.2020.9.3.223
  33. Behera JP, Mohanty B, Ramani YR, Rath B, Pradhan S. Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease. Indian Journal of Pharmacology. 2012; 44(5): 614-618. doi: 10.4103/ 0253-7613.100389
  34. Gautam MK, Ghatule RR, Singh A, Purohit V, Gangwar M, Kumar M, Goel RK. Healing effects of Aegle marmelos (L.) Correa fruit extract on experimental colitis. Indian Journal of Experimental Biology. 2013; 51(2): 157-164. PMID: 23923609.
  35. Ghatule RR, Gautam MK, Goel S, Singh A, Joshi VK, Goel RK. Protective effects of Aegle marmelos fruit pulp on 2, 4, 6-trinitrobenzene sulfonic acid-induced experimental colitis. Pharmacognosy Magazine. 2014; 10(S-1): S147-S152. doi: 10.4103/0973-1296.127366
  36. Langhorst J, Varnhagen I, Schneider SB, Albrecht U, Rueffer A, Stange R, Michalsen A, Dobos GJ. Randomised clinical trial: A herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis-a double-blind, double-dummy study. Alimentary Pharmacology and Therapeutics. 2013; 38(5): 490-500. doi: 10.1111/apt.12397
  37. Lebda MA, Mostafa RE, Taha NM, Abd El-Maksoud EM, Tohamy HG, Al Jaouni SK, El-Far AH, Elfeky MS. Commiphora myrrh supplementation protects and cures ethanol-induced oxidative alterations of gastric ulceration in rats. Antioxidants (Basel). 2021; 10(11): 1836. doi: 10.3390/antiox10111836
  38. Mostafa RE, Taha NM, Lebda MA, Elfeky MS, AbdEl-Maksoud EM. Effect of Commiphora myrrh oil and extract on experimentally induced gastritis in rats. Alexandria Journal of Veterinary Sciences. 2021; 70(2): 1-6. doi: 10.5455/ajvs.84385
  39. Brückner M, Westphal S, Domschke W, Kucharzik T, Lügering A. Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. Journal of Crohn's and Colitis. 2012; 6(2): 226-235. doi: 10.1016/j.crohns.2011.08.012
  40. Oz HS, Chen T, de Villiers WJ. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Frontiers in Immunology. 2013; 4: 132. doi: 10.3389/fimmu.2013.00132
  41. Dryden GW, Lam A, Beatty K, Qazzaz HH, McClain CJ. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis. Inflammatory Bowel Disease. 2013; 19(9): 1904-1912. doi: 10.1097/MIB.0b013e31828f5198
  42. Minaiyan M, Ghannadi AR, Afsharipour M, Mahzouni P. Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats. Research in Pharmaceutical Sciences. 2011; 6: 13-21. PMID: 22049274.
  43. Minaiyan M, Ghannadi A, Etemad M, Mahzouni P. A study of the effects of Cydonia oblonga Miller (Quince) on TNBS-induced ulcerative colitis in rats. Research in Pharmaceutical Sciences. 2012; 7(2): 103-110. PMID: 23181087.
  44. Silva BM, Andrade PB, Martins RC, Valentão P, Ferreres F, Seabra RM, Ferreira MA. Quince (Cydonia oblonga miller) fruit characterization using principal component analysis. Journal of Agriculture and Food Chemistry. 2005; 53(1): 111-122. doi: 10.1021/jf040321k
  45. Phatak UP, Rojas-Velasquez D, Porto A, Pashankar DS. Prevalence and patterns of marijuana use in young adults with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2017; 64(2): 261-264. doi: 10.1097/MPG.0000000000001474
  46. Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. Inflammatory Bowel Disease. 2014; 20(3): 472-480. doi: 10.1097/01.MIB.0000440982.79036.d6
  47. Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug and Alcohol Dependence. 2017; 172: 9-13. doi: 10.1016/j.drugalcdep.2016.11.030
  48. Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, Tiwari V, Makharia G, Ahuja V. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double-blind placebo-controlled trial. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017; 8(2): 147-154. doi: 10.4292/wjgpt.v8.i2.147
  49. Lee D, Kim HS, Shin E, Do SG, Lee CK, Kim YM, et al. Polysaccharide isolated from Aloe vera gel suppresses ovalbumin-induced food allergy through inhibition of Th2 immunity in mice. Biomedical Pharmacotherapy. 2018; 101: 201-210. doi: 10.1016/j.biopha.2018.02.061
  50. Lang A, Salomon N, Wu JC, Kopylov U, Lahat A, Har-Noy O, et al. Curcumin in combination with Mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clinical Gastroenterology and Hepatology. 2015; 13(8): 1444-9.e1. doi: 10.1016/j.cgh.2015.02.019
  51. Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytotherapy Research. 2020; 34(5): 1123-1133. doi: 10.1002/ptr.6581
  52. Irving PM, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N, et al. A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflammatory Bowel Disease. 2018; 24(4): 714-724. doi: 10.1093/ibd/izy002
  53. Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Alimentary Pharmacology  and Therapeutics. 2011; 33(2): 194-202. doi: 10.1111/j.1365-2036.2010.04515.x
  54. Fang X, Feng J, Zhu X, Feng D, Zheng L. Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment. Molecular Therapeutics. 2024; 32(4): 890-909. doi: 10.1016/j.ymthe.2024.02.021
  55. Mu J, Zhuang X, Wang Q, Jiang H, Deng ZB, Wang B, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Molecular Nutrition and Food Research. 2014; 58(7): 1561-1573. doi: 10.1002/mnfr.201300729
  56. Gao C, Zhou Y, Chen Z, Li H, Xiao Y, Hao W, et al. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theragnostic. 2022; 12(12): 5596-5614. doi: 10.7150/thno.73650
  57. Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharmaceutica Sinica B. 2022; 12(2): 907-923. doi: 10.1016/j.apsb.2021.08.016
  58. Taha HS, El-Bahr MK, Seif-El-Nasr MM. In vitro studies on Egyptian Catharanthus roseus (L.). Ii. effect of biotic and abiotic stress on indole alkaloids production. Journal of Applied Sciences Research. 2009; 5: 1826-1831. Corpus ID: 202897051.
  59. Cushnie TP, Cushnie B, Lamb AJ. Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities. International Journal of Antimicrobial Agents. 2014; 44(5): 377-386. doi: 10.1016/ j.ijantimicag.2014.06.001
  60. Lv Q, Qiao SM, Xia Y, Shi C, Xia YF, Chou GX, et al. Norisoboldine ameliorates DSS-induced ulcerative colitis in mice through induction of regulatory T cells in colons. International Immunopharmacology. 2015; 29(2): 787-797. doi: 10.1016/j.intimp.2015.08.040
  61. Zhang XJ, Yuan ZW, Qu C, Yu XT, Huang T, Chen PV, et al. Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota. Pharmacological Research. 2018; 137: 34-46. doi: 10.1016/j.phrs.2018.09.010

Submitted date:
08/09/2025

Reviewed date:
08/24/2025

Accepted date:
08/31/2025

68b4dc80a953955e32089304 mjmmr Articles
Links & Downloads
0000-0000 (Electronic)
Mediterr J Med Med Sci ©2025 All rights reserved.

Mediterr J Med Med Sci

Share this page
Page Sections